343 related articles for article (PubMed ID: 18339795)
41. [Screening of Differential Expression Proteins in Rat Brain Tissues after DAI by iTRAQ-LC-MS/MS].
Chen Q; Bai J; Zhang WF
Fa Yi Xue Za Zhi; 2017 Aug; 33(4):348-352. PubMed ID: 29219262
[TBL] [Abstract][Full Text] [Related]
42. Relative protein quantification and accessible biology in lung tumor proteomes from four LC-MS/MS discovery platforms.
Stewart PA; Fang B; Slebos RJ; Zhang G; Borne AL; Fellows K; Teer JK; Chen YA; Welsh E; Eschrich SA; Haura EB; Koomen JM
Proteomics; 2017 Mar; 17(6):. PubMed ID: 28195392
[TBL] [Abstract][Full Text] [Related]
43. Expression of cDNA clones by coupled in vitro transcription/translation and transfection into COS-1 cells: protein mapping in two-dimensional gels.
Madsen P; Gromov P; Celis JE
Electrophoresis; 1995 Dec; 16(12):2258-61. PubMed ID: 8824785
[TBL] [Abstract][Full Text] [Related]
44. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis.
Dowling P; Wormald R; Meleady P; Henry M; Curran A; Clynes M
J Proteomics; 2008 Jul; 71(2):168-75. PubMed ID: 18617144
[TBL] [Abstract][Full Text] [Related]
45. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics.
Zhou L; Beuerman RW; Chan CM; Zhao SZ; Li XR; Yang H; Tong L; Liu S; Stern ME; Tan D
J Proteome Res; 2009 Nov; 8(11):4889-905. PubMed ID: 19705875
[TBL] [Abstract][Full Text] [Related]
46. S100 Proteins as Biomarkers in Risk Estimations for Malignant Transformation in Oral Lesions.
Probstmeier R; Kraus D; Wenghoefer M; Winter J
Methods Mol Biol; 2019; 1929():763-771. PubMed ID: 30710310
[TBL] [Abstract][Full Text] [Related]
47. [Analysis of the effects of 17beta-oestradiol and serum deprivation on the contents of proteins in breast cancer cells by isobaric tags for relative and absolute quantification and two-dimensional liquid chromatography-tandem mass spectrometry].
Zhu L; Ni G; Zhang Z; Xu X; Hu X; Li W
Se Pu; 2009 May; 27(3):270-8. PubMed ID: 19803128
[TBL] [Abstract][Full Text] [Related]
48. 2D-DIGE proteomic characterization of head and neck squamous cell carcinoma.
Merkley MA; Weinberger PM; Jackson LL; Podolsky RH; Lee JR; Dynan WS
Otolaryngol Head Neck Surg; 2009 Nov; 141(5):626-32. PubMed ID: 19861202
[TBL] [Abstract][Full Text] [Related]
49. Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma.
Onsurathum S; Haonon O; Pinlaor P; Pairojkul C; Khuntikeo N; Thanan R; Roytrakul S; Pinlaor S
Tumour Biol; 2018 Apr; 40(4):1010428318767195. PubMed ID: 29629840
[TBL] [Abstract][Full Text] [Related]
50. Verification of endometrial tissue biomarkers previously discovered using mass spectrometry-based proteomics by means of immunohistochemistry in a tissue microarray format.
Dubé V; Grigull J; DeSouza LV; Ghanny S; Colgan TJ; Romaschin AD; Siu KW
J Proteome Res; 2007 Jul; 6(7):2648-55. PubMed ID: 17552551
[TBL] [Abstract][Full Text] [Related]
51. A technical triade for proteomic identification and characterization of cancer biomarkers.
Melle C; Ernst G; Schimmel B; Bleul A; Koscielny S; Wiesner A; Bogumil R; Möller U; Osterloh D; Halbhuber KJ; von Eggeling F
Cancer Res; 2004 Jun; 64(12):4099-104. PubMed ID: 15205318
[TBL] [Abstract][Full Text] [Related]
52. A comparative proteomic analysis of HepG2 cells incubated by S(-) and R(+) enantiomers of anti-coagulating drug warfarin.
Bai J; Sadrolodabaee L; Ching CB; Chowbay B; Ning Chen W
Proteomics; 2010 Apr; 10(7):1463-73. PubMed ID: 20140906
[TBL] [Abstract][Full Text] [Related]
53. An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.
Mangé A; Dimitrakopoulos L; Soosaipillai A; Coopman P; Diamandis EP; Solassol J
J Proteomics; 2016 Jun; 142():114-21. PubMed ID: 27168011
[TBL] [Abstract][Full Text] [Related]
54. Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry.
Melle C; Ernst G; Schimmel B; Bleul A; Koscielny S; Wiesner A; Bogumil R; Moller U; Osterloh D; Halbhuber KJ; von Eggeling F
Mol Cell Proteomics; 2003 Jul; 2(7):443-52. PubMed ID: 12824440
[TBL] [Abstract][Full Text] [Related]
55. Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling.
Li M; Gray W; Zhang H; Chung CH; Billheimer D; Yarbrough WG; Liebler DC; Shyr Y; Slebos RJ
J Proteome Res; 2010 Aug; 9(8):4295-305. PubMed ID: 20586475
[TBL] [Abstract][Full Text] [Related]
56. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
[TBL] [Abstract][Full Text] [Related]
57. Crystal Structure of Human Profilaggrin S100 Domain and Identification of Target Proteins Annexin II, Stratifin, and HSP27.
Bunick CG; Presland RB; Lawrence OT; Pearton DJ; Milstone LM; Steitz TA
J Invest Dermatol; 2015 Jul; 135(7):1801-1809. PubMed ID: 25760235
[TBL] [Abstract][Full Text] [Related]
58. iTRAQ-Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer.
Jiang Z; Zhang C; Gan L; Jia Y; Xiong Y; Chen Y; Wang Z; Wang L; Luo H; Li J; Zhu R; Ji X; Yu Q; Wang L
Proteomics Clin Appl; 2019 Jul; 13(4):e1800038. PubMed ID: 30485682
[TBL] [Abstract][Full Text] [Related]
59. Epidermal differentiation complex (locus 1q21) gene expression in head and neck cancer and normal mucosa.
Tyszkiewicz T; Jarzab M; Szymczyk C; Kowal M; Krajewska J; Jaworska M; Fraczek M; Krajewska A; Hadas E; Swierniak M; Markowski J; Lange D; Poltorak S; Wiench M; Krecicki T; Jarzab J; Maciejewski A
Folia Histochem Cytobiol; 2014; 52(2):79-89. PubMed ID: 25007175
[TBL] [Abstract][Full Text] [Related]
60. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.
Cui L; Cheng S; Liu X; Messadi D; Yang Y; Hu S
Oncotarget; 2016 Dec; 7(50):82634-82647. PubMed ID: 27811365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
